| |
| |
|
| Insider
Information: |
Schuth Alexander O. |
| Relationship: |
COFO and Secretary |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
187,341 |
|
|
Indirect Shares
|
523,749 |
|
|
| Direct
Value |
$3,883,579 |
|
|
|
Indirect Value
|
$10,857,317 |
|
|
| Total
Shares |
711,090 |
|
|
| Total
Value |
$14,740,896 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
15
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
13
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -30.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
COFO and Secretary |
2024-02-14 |
187,341 |
2024-02-14 |
523,749 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
53,720 |
170,157 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-01-05 |
4 |
S |
$19.43 |
$193,756 |
I/I |
(9,972) |
539,307 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-02-08 |
4 |
OE |
$0.68 |
$34,000 |
D/D |
50,000 |
210,185 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-02-13 |
4 |
AS |
$17.29 |
$46,960 |
D/D |
(2,716) |
207,469 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-02-14 |
4 |
AS |
$17.66 |
$355,460 |
D/D |
(20,128) |
187,341 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2018-06-22 |
4 |
OE |
$5.28 |
$31,247 |
D/D |
5,918 |
5,918 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2018-10-02 |
4 |
OE |
$5.28 |
$62,498 |
D/D |
7,043 |
12,961 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2018-12-10 |
4 |
AS |
$20.18 |
$50,450 |
I/I |
(2,500) |
682,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2018-12-11 |
4 |
AS |
$20.22 |
$50,550 |
I/I |
(2,500) |
680,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2018-12-12 |
4 |
AS |
$20.80 |
$52,000 |
I/I |
(2,500) |
677,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-01-09 |
4 |
AS |
$20.31 |
$50,775 |
I/I |
(2,500) |
675,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-01-10 |
4 |
AS |
$19.99 |
$49,975 |
I/I |
(2,500) |
672,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-01-11 |
4 |
AS |
$20.80 |
$52,000 |
I/I |
(2,500) |
670,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-02-08 |
4 |
AS |
$18.11 |
$45,275 |
I/I |
(2,500) |
667,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-02-11 |
4 |
AS |
$18.74 |
$47,622 |
I/I |
(2,500) |
665,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-02-12 |
4 |
AS |
$19.73 |
$50,192 |
I/I |
(2,500) |
662,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-03-11 |
4 |
AS |
$21.20 |
$52,635 |
I/I |
(2,475) |
660,114 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-03-12 |
4 |
AS |
$22.40 |
$56,291 |
I/I |
(2,513) |
657,601 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-03-13 |
4 |
AS |
$23.60 |
$60,387 |
I/I |
(2,512) |
655,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-04-09 |
4 |
AS |
$28.17 |
$69,721 |
I/I |
(2,475) |
652,614 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-04-10 |
4 |
AS |
$28.26 |
$71,017 |
I/I |
(2,513) |
650,101 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-04-11 |
4 |
AS |
$27.73 |
$69,658 |
I/I |
(2,512) |
647,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-05-09 |
4 |
AS |
$22.86 |
$57,150 |
I/I |
(2,500) |
645,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-05-10 |
4 |
AS |
$22.19 |
$55,475 |
I/I |
(2,500) |
642,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-05-13 |
4 |
AS |
$21.09 |
$52,725 |
I/I |
(2,500) |
640,089 |
0 |
- |
|
90 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
